Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDTaiwan Liposome Company, Ltd. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 06/29/2021 | Q2 2021 | -$1.79 | $160.18 M | |||
| 03/30/2021 | Q1 2021 | -$4.78 | $37.62 M | |||
| 12/30/2020 | Q4 2020 | -$6.96 | $12.08 M | |||
| 09/29/2020 | Q3 2020 | -$5.56 | $66.10 M | |||
| 06/29/2020 | Q2 2020 | -$6.56 | $11.78 M | |||
| 03/30/2020 | Q1 2020 | -$5.80 | $11.97 M | |||
| 12/30/2019 | Q4 2019 | -$8.60 | $11.95 M | |||
| 09/29/2019 | Q3 2019 | -$5.60 | $18.84 M | |||
| 06/29/2019 | Q2 2019 | -$7.58 | $20.59 M | |||
| 03/30/2019 | Q1 2019 | -$3.52 | $157.77 M | |||
| 12/30/2018 | Q4 2018 | -$10.94 | $17.38 M | |||
| 09/29/2018 | Q3 2018 | -$7.04 | $15.28 M | |||
| 06/29/2018 | Q2 2018 | -$8.36 | $15.57 M | |||
| 03/30/2018 | Q1 2018 | -$5.98 | $14.09 M | |||
| 12/30/2017 | Q4 2017 | -$9.40 | $12.40 M | |||
| 09/29/2017 | Q3 2017 | -$8.06 | $13.37 M | |||
| 06/29/2017 | Q2 2017 | -$8.18 | $12.01 M | |||
| 03/30/2017 | Q1 2017 | -$5.74 | $11.86 M | |||
| 12/30/2016 | Q4 2016 | -$9.61 | $12.64 M | |||
| 09/29/2016 | Q3 2016 | -$8.48 | $9.82 M |
Taiwan Liposome Company, Ltd. Earnings: FAQ's
Did Taiwan Liposome Company, Ltd. beat their earnings estimates last
quarter?
In the previous quarter, Taiwan Liposome Company, Ltd. (:TLC) reported $-0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.13 by $0.09.
How can I listen to Taiwan Liposome Company, Ltd.'s earnings conference
call?
The conference call for Taiwan Liposome Company, Ltd.'s latest earnings report can be listened to online.
How can I read Taiwan Liposome Company, Ltd.'s conference call transcript?
The conference call transcript for Taiwan Liposome Company, Ltd.'s latest earnings report can be read online.
How much revenue does Taiwan Liposome Company, Ltd. generate each year?
Taiwan Liposome Company, Ltd. (:TLC) has a recorded annual revenue of $101.93 M.
How much profit does Taiwan Liposome Company, Ltd. generate each year?
Taiwan Liposome Company, Ltd. (:TLC) has a recorded net income of $101.93 M. Taiwan Liposome Company, Ltd. has generated $-24.89 earnings per share over the last four quarters.
What is Taiwan Liposome Company, Ltd.'s price-to-earnings ratio?
Taiwan Liposome Company, Ltd. (:TLC) has a price-to-earnings ratio of -9.29 and price/earnings-to-growth ratio is -0.09.